8W83
HLA-DQ2.5-alpha1 gliadin peptide in complex with DQN0344AE02
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | PHOTON FACTORY BEAMLINE BL-17A |
| Synchrotron site | Photon Factory |
| Beamline | BL-17A |
| Temperature [K] | 95 |
| Detector technology | PIXEL |
| Collection date | 2018-03-14 |
| Detector | DECTRIS PILATUS3 S 6M |
| Wavelength(s) | 0.980000 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 87.488, 174.235, 129.656 |
| Unit cell angles | 90.00, 93.17, 90.00 |
Refinement procedure
| Resolution | 54.860 - 2.818 |
| R-factor | 0.28 |
| Rwork | 0.278 |
| R-free | 0.32090 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 1s9v |
| RMSD bond length | 0.004 |
| RMSD bond angle | 0.590 |
| Data reduction software | XDS (Jan 31, 2020) |
| Data scaling software | Aimless (0.7.4) |
| Phasing software | PHASER |
| Refinement software | BUSTER (2.11.8 (8-JUN-2022)) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 129.458 | 129.458 | 3.270 |
| High resolution limit [Å] | 2.818 | 9.881 | 2.818 |
| Rmerge | 0.500 | 0.090 | 1.237 |
| Rmeas | 0.547 | 0.099 | 1.358 |
| Rpim | 0.217 | 0.040 | 0.551 |
| Total number of observations | 285587 | 13372 | 13128 |
| Number of reflections | 44543 | 2227 | 2228 |
| <I/σ(I)> | 4.68 | 13.21 | 1.67 |
| Completeness [%] | 92.7 | 99.7 | 72.8 |
| Completeness (spherical) [%] | 47.7 | 99.7 | 6.7 |
| Completeness (ellipsoidal) [%] | 92.7 | 99.7 | 72.8 |
| Redundancy | 6.41 | 6 | 5.89 |
| CC(1/2) | 0.900 | 0.990 | 0.593 |
| Anomalous completeness (spherical) | 46.8 | 98.3 | 6.4 |
| Anomalous completeness | 91.6 | 98.3 | 71.8 |
| Anomalous redundancy | 3.3 | 3.2 | 3.0 |
| CC(ano) | 0.220 | 0.382 | 0.097 |
| |DANO|/σ(DANO) | 0.8 | 0.7 | 0.8 |
| Diffraction limits | Principal axes of ellipsoid fitted to diffraction cut-off surface |
| 4.256 Å | 0.757, 0.757, 0.757 |
| 3.653 Å | 0.000, 0.000, 0.000 |
| 2.817 Å | -0.653, -0.653, -0.653 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 294 | 0.1 M HEPES (pH7.5), 25.0 %w/v Polyethylene glycol 1,000, and 20 %v/v Glycerol as cryoprotectant |






